Targeted endothelial delivery of nanosized catalase immunoconjugates protects lung grafts donated after cardiac death

Transplantation

Volumn 92, Issue 4, 2011, Pages 380-387

  Preissler, Gerhard ^a   Loehe, Florian ^a,b   Huff, Ines V ^a   Ebersberger, Ulrich ^a   Shuvaev, Vladimir V ^c   Bittmann, Iris ^d   Hermanns, Iris ^e   Kirkpatrick, James C ^e   Fischer, Karl ^e   Eichhorn, Martin E ^a   Winter, Hauke ^a   Jauch, Karl W ^a   Albelda, Steven M ^c   Muzykantov, Vladimir R ^c   Wiewrodt, Rainer ^c,e,f  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b Klinikum Landshut   (Germany)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d Institute of Pathology   (Germany)

^e JOHANNES GUTENBERG UNIVERSITY   (Germany)

^f UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Antioxidants; Donors after cardiac death; Ischemia reperfusion injury; Lung transplantation; Nanoparticle; Vascular targeting

Indexed keywords

ANTIBODY CONJUGATE; CATALASE CD31 ANTIGEN ANTIBODY CONJUGATE; CD31 ANTIGEN; NANOPARTICLE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CRYOPRESERVATION; ENDOTHELIUM CELL; GAS EXCHANGE; HEART ARREST; HEART DEATH; ISCHEMIA; LIPID PEROXIDATION; LUNG DONOR; LUNG FUNCTION; LUNG LAVAGE; LUNG PARENCHYMA; LUNG TRANSPLANTATION; MICROCIRCULATION; NONHUMAN; ORGAN DONOR; PRIORITY JOURNAL; PULMONARY SHUNT; REPERFUSION; STERNOTOMY; SWINE;

ANIMALS; ANTIBODIES; ANTIGENS, CD31; CATALASE; DEATH; DRUG DELIVERY SYSTEMS; ENDOTHELIAL CELLS; HUMANS; IMMUNOCONJUGATES; LUNG TRANSPLANTATION; NANOPARTICLES; ORGAN PRESERVATION; OXIDATIVE STRESS; PULMONARY GAS EXCHANGE; SUS SCROFA; TISSUE DONORS;

EID: 80051783177     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318226bc6b     Document Type: Article

References (46)

1. De Vleeschauwer S, van Raemdonck D, Vanaudenaerde B, et al. Early outcome after lung transplantation from non-heart-beating donors is comparable to heart-beating donors. J Heart Lung Transplant 2009;28:380.
2. Erasmus ME, Verschuuren EA, Nijkamp DM, et al. Lung transplantation from nonheparinized category III non-heart-beating donors. A single-centre report. Transplantation 2010;89:452.
3. Mason DP, Thuita L, Alster JM, et al. Should lung transplantation be performed using donation after cardiac death? The United States experience. J Thorac Cardiovasc Surg 2008;136:1061.
4. Steinbrook R. Organ donation after cardiac death. N Engl J Med 2007;357:209.
5. Summers DM, Counter C, Johnson RJ, et al. Is the increase in DCD organ donors in the United Kingdom contributing to a decline in DBD donors? Transplantation 2010;90:1506.
6. Nijkamp DM, van der Bij W, Verschuuren EA, et al. Non-heart-beating lung donation: Howbigisthepool? J Heart Lung Transplant 2008;27:1040.
7. Kootstra G. The asystolic, or non-heartbeating, donor. Transplantation 1997;63:917.
8. de Perrot M, Liu M, Waddell TK, et al. Ischemia-reperfusion-induced lung injury. Am JRespir Crit Care Med 2003;167:490.
9. Wilkes DS, Egan TM, Reynolds HY. Lung transplantation: Opportunities for research and clinical advancement. Am J Respir Crit Care Med 2005;172:944.
10. Snell GI, Rabinov M, Griffiths A, et al. Pulmonary allograft ischemic time: An important predictor of survival after lung transplantation. J Heart Lung Transplant 1996;15:160.
11. Van Raemdonck D. Thoracic organs: Current preservation technology and future prospects; part 1: Lung. Curr Opin Organ Transplant 2010;15:150.
12. Snell GI, Levvey BJ, Oto T, et al. Early lung transplantation success utilizing controlled donation after cardiac death donors. Am J Transplant 2008;8:1282.
13. de Antonio DG, Marcos R, Laporta R, et al. Results of clinical lung transplant from uncontrolled non-heart-beating donors. J Heart Lung Transplant 2007;26:529.
14. al Mehdi AB, Zhao G, Dodia C, et al. Endothelial NADPH oxidase as the source of oxidants in lungs exposed to ischemia or high K+. Circ Res 1998;83:730.
15. al Mehdi AB, Shuman H, Fisher AB. Intracellular generation of reactive oxygen species during nonhypoxic lung ischemia. Am J Physiol 1997;272:L294.
16. Fisher AB, Dodia C, Tan ZT, et al. Oxygen-dependent lipid peroxidation during lung ischemia. J Clin Invest 1991;88:674.
17. Fisher AB, al Mehdi AB, Muzykantov V. Activation of endothelial NADPH oxidase as the source of a reactive oxygen species in lung ischemia. Chest 1999;116:25S.
18. Eppinger MJ, Deeb GM, Bolling SF, et al. Mediators of ischemiareperfusion injury of rat lung. Am J Pathol 1997;150:1773.
19. Novick RJ, Gehman KE, Ali IS, et al. Lung preservation: The importance of endothelial and alveolar type II cell integrity. Ann Thorac Surg 1996;62:302.
20. King RC, Binns OA, Rodriguez F, et al. Reperfusion injury significantly impacts clinical outcome after pulmonary transplantation. Ann Thorac Surg 2000;69:1681.
21. Muzykantov VR, Christofidou-Solomidou M, Balyasnikova I, et al. Streptavidin facilitates internalization and pulmonary targeting of an anti-endothelial cell antibody (platelet-endothelial cell adhesion molecule 1): A strategy for vascular immunotargeting of drugs. Proc Natl Acad Sci USA 1999;96:2379.
22. Scherpereel A, Rome JJ, Wiewrodt R, et al. Platelet-endothelial cell adhesion molecule-1-directed immunotargeting to cardiopulmonary vasculature. J Pharmacol Exp Ther 2002;300:777.
23. Nowak K, Weih S, Metzger R, et al. Immunotargeting of catalase to lung endothelium via anti-angiotensin-converting enzyme antibodies attenuates ischemia-reperfusion injury of the lung in vivo. Am J Physiol Lung Cell Mol Physiol x 2007;293:L162.
24. Christofidou-Solomidou M, Scherpereel A, Wiewrodt R, et al. PECAM-directed delivery of catalase to endothelium protects against pulmonary vascular oxidative stress. Am JPhysiol Lung Cell Mol Physiol 2003;285:L283.
25. Loehe F, Mueller C, Annecke T, et al. Pulmonary graft function after long-term preservation of non-heart-beating donor lungs. Ann Thorac Surg 2000;69:1556.
26. Loehe F, Mueller C, Annecke T, et al. Tissue damage of non-heartbeating donor lungs after long-term preservation: Evaluation of histologic alteration, bronchoalveolar lavage, and energymetabolism. Shock 2002;17:502.
27. Loehe F, Preissler G, Annecke T, et al. Continuous infusion of nitroglycerin improves pulmonary graft function of non-heart-beating donor lungs. Transplantation 2004;77:1803.
28. Date H, Matsumura A, Manchester JK, et al. Changes in alveolar oxygen and carbon-dioxide concentration and oxygen-consumption during lung preservation-The maintenance of aerobic metabolism during lung preservation. J Thorac Cardiovasc Surg 1993;105:492.
29. D'Armini AM, Roberts CS, Griffith PK, et al. When does the lung die? I. Histochemical evidence of pulmonary viability after "death". J Heart Lung Transplant 1994;13:741.
30. Kozower BD, Christofidou-Solomidou M, Sweitzer TD, et al. Immunotargeting of catalase to the pulmonary endothelium alleviates oxidative stress and reduces acute lung transplantation injury. Nat Biotechnol 2003;21:392.
31. Oto T, Levvey BJ, Pilcher DV, et al. Evaluation of the oxygenation ratio in the definition of early graft dysfunction after lung transplantation. J Thorac Cardiovasc Surg 2005;130:180.
32. Chatila WM, Furukawa S, Gaughan JP, et al. Respiratory failure after lung transplantation. Chest 2003;123:165.
33. Thabut G, Mal H, Cerrina J, et al. Graft ischemic time and outcome of lung transplantation: Amulticenter analysis. Am J Respir Crit Care Med 2005;171:786.
34. Fiser SM, Tribble CG, Long SM, et al. Ischemia-reperfusion injury after lung transplantation increases risk of late bronchiolitis obliterans syndrome. Ann Thorac Surg 2002;73:1041.
35. Perkowski S, Scherpereel A, Murciano JC, et al. Dissociation between alveolar transmigration of neutrophils and lung injury in hyperoxia. Am J Physiol Lung Cell Mol Physiol 2006;291:L1050.
36. Maathuis MH, de Groot M, Ploeg RJ, et al. Deterioration of endothelial and smooth muscle cell function in DCD kidneys after static cold storage in IGL-1 or UW. J Surg Res 2009;152:231.
37. Egan TM, Hoffmann SC, Sevala M, et al. Nitroglycerin reperfusion reduces ischemia-reperfusion injury in non-heart-beating donor lungs. J Heart Lung Transplant 2006;25:110.
38. Pinsky DJ, Naka Y, Chowdhury NC, et al. The nitric oxide/cyclic GMP pathway in organ transplantation: Critical role in successful lung preservation. Proc Natl Acad Sci USA 1994;91:12086.
39. Shuvaev VV, Tliba S, Nakada M, et al. Platelet-endothelial cell adhesion molecule-1-directed endothelial targeting of superoxide dismutase alleviates oxidative stress caused by either extracellular or intracellular superoxide. J Pharmacol Exp Ther 2007;323:450.
40. Preissler G, Loehe F, Ebersberger U, et al. Recipient treatment with L-arginine attenuates donor lung injury associated with hemorrhagic shock. Transplantation 2009;87:1602.
41. Cooke JP, Tsao PS. Cytoprotective effects of nitric oxide. Circulation 1993;88:2451.
42. Ding BS, Hong N, Murciano JC, et al. Prophylactic thrombolysis by thrombin-activated latent prourokinase targeted to PECAM-1 in the pulmonary vasculature. Blood 2008;111:1999.
43. Yeung JC, Cypel M, Waddell TK, et al. Update on donor assessment, resuscitation, and acceptance criteria, including novel techniques-Non-heart- beating donor lung retrieval and ex vivo donor lung perfusion. Thorac Surg Clin 2009;19:261.
44. Ingemansson R, Eyjolfsson A, Mared L, et al. Clinical transplantation of initially rejected donor lungs after reconditioning ex vivo. Ann Thorac Surg 2009;87:255.
45. Wiewrodt R, Thomas AP, Cipelletti L, et al. Size-dependent intracellular immunotargeting of therapeutic cargoes into endothelial cells. Blood 2002;99:912.
46. Peterson GL. A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem 1977;83:346.